VERA Vera Therapeutics, Inc.
Nasdaq · SEC CIK 1831828 · EDGAR
- Bought, last 12 months
- $250.0K 1 purchases by 1 insiders
- Sold, last 12 months
- $12.32M 21 sales by 8 insiders
- Filings on record
- 180 since 2021-07-15, latest 2026-09-17 16:28
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Fordyce Marshall | Pres AND CEO, Dir | — | $9.73M |
| Turner William D. | Chief Regulatory Off | — | $1.45M |
| Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | — | $566.8K |
| ENRIGHT PATRICK G | Dir | $250.0K | — |
| Grant Sean | CFO | — | $207.8K |
| JOHNSON DAVID LEE | COO | — | $108.3K |
| Carter Jason S | CLO | — | $107.5K |
| Brenner Robert | Chief Medical Off | — | $90.3K |
| Skelton Laurence Matthew | Chief Commercial Off | — | $66.4K |
| Boman Nancy Lee | Chief Regulatory Off | — | — |
Transactions 170
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-17 16:28 | 2026-09-15 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +18.5K | 253.7K | +8% | +$53.6K |
| DT | 2026-09-17 16:28 | 2026-09-15 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $37.00 | -18.5K | 235.2K | -7% | -$684.5K |
| D | 2026-09-14 16:28 | 2026-09-11 | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | M - OptEx | $3.94 | +5,000 | 80.8K | +7% | +$19.7K |
| DT | 2026-09-04 16:15 | 2026-09-02 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +18.5K | 253.7K | +8% | +$53.6K |
| DT | 2026-09-04 16:15 | 2026-09-02 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $35.12 | -18.5K | 235.2K | -7% | -$649.6K |
| DAT | 2026-08-12 18:42 | 2026-07-07 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +46.2K | 281.5K | +20% | +$134.0K |
| DMAT | 2026-08-12 18:42 | 2026-07-07 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $42.30 | -46.2K | 235.2K | -16% | -$1.96M |
| DAT | 2026-08-12 18:41 | 2026-06-23 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +18.5K | 253.7K | +8% | +$53.6K |
| DMAT | 2026-08-12 18:41 | 2026-06-23 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $37.93 | -18.5K | 235.2K | -7% | -$701.8K |
| DAT | 2026-08-12 18:39 | 2026-05-12 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +18.5K | 253.7K | +8% | +$53.6K |
| DMAT | 2026-08-12 18:39 | 2026-05-12 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $36.74 | -18.5K | 235.2K | -7% | -$679.7K |
| D | 2026-08-05 16:14 | 2026-08-03 | VERA | Boman Nancy Lee | Chief Regulatory Off | A - Grant | $0.00 | +45.0K | 45.0K | New | $0 |
| MT | 2026-07-09 16:45 | 2026-07-07 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $42.30 | -46.2K | 152.0K | -23% | -$1.96M |
| MT | 2026-06-24 16:55 | 2026-06-23 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $37.93 | -18.5K | 198.2K | -9% | -$701.8K |
| MT | 2026-05-13 16:26 | 2026-05-12 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $36.74 | -18.5K | 216.7K | -8% | -$679.7K |
| MT | 2026-04-15 16:57 | 2026-04-14 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $44.05 | -23.0K | 235.2K | -9% | -$1.01M |
| D | 2026-03-25 | 2026-03-23 | VERA | Wright-Mitchell Jane | CLO | A - Grant | $0.00 | +42.4K | 42.4K | New | $0 |
| D | 2026-03-16 | 2026-03-13 | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | M - OptEx | $3.94 | +10.0K | 75.8K | +15% | +$39.4K |
| 2026-02-25 | 2026-02-23 | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | S - Sale | $41.98 | -3,117 | 64.7K | -5% | -$130.9K | |
| 2026-02-25 | 2026-02-23 | VERA | JOHNSON DAVID LEE | COO | S - Sale | $41.98 | -2,579 | 45.7K | -5% | -$108.3K | |
| 2026-02-25 | 2026-02-23 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $41.98 | -16.9K | 257.2K | -6% | -$710.5K | |
| 2026-02-25 | 2026-02-23 | VERA | Skelton Laurence Matthew | Chief Commercial Off | S - Sale | $41.98 | -1,582 | 64.2K | -2% | -$66.4K | |
| 2026-02-25 | 2026-02-23 | VERA | Brenner Robert | Chief Medical Off | S - Sale | $41.98 | -2,151 | 50.9K | -4% | -$90.3K | |
| 2026-02-25 | 2026-02-23 | VERA | Grant Sean | CFO | S - Sale | $41.98 | -4,949 | 114.2K | -4% | -$207.8K | |
| 2026-02-25 | 2026-02-23 | VERA | Turner William D. | Chief Regulatory Off | S - Sale | $41.98 | -2,187 | 45.3K | -5% | -$91.8K | |
| D | 2026-02-06 | 2026-02-04 | VERA | JOHNSON DAVID LEE | COO | A - Grant | $0.00 | +20.0K | 48.3K | +71% | $0 |
| D | 2026-02-06 | 2026-02-04 | VERA | Turner William D. | Chief Regulatory Off | A - Grant | $0.00 | +25.0K | 47.5K | +111% | $0 |
| D | 2026-02-06 | 2026-02-04 | VERA | Skelton Laurence Matthew | Chief Commercial Off | A - Grant | $0.00 | +20.0K | 65.8K | +44% | $0 |
| D | 2026-02-06 | 2026-02-04 | VERA | Brenner Robert | Chief Medical Off | A - Grant | $0.00 | +25.0K | 53.1K | +89% | $0 |
| D | 2026-02-06 | 2026-02-04 | VERA | Grant Sean | CFO | A - Grant | $0.00 | +25.0K | 119.1K | +27% | $0 |
| D | 2026-02-06 | 2026-02-04 | VERA | Fordyce Marshall | Pres AND CEO, Dir | A - Grant | $0.00 | +68.8K | 274.1K | +34% | $0 |
| D | 2026-02-06 | 2026-02-04 | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | A - Grant | $0.00 | +10.0K | 67.8K | +17% | $0 |
| DT | 2025-12-17 | 2025-12-15 | VERA | Turner William D. | Chief Regulatory Off | M - OptEx | $15.53 | +10.0K | 32.5K | +44% | +$155.3K |
| DT | 2025-12-17 | 2025-12-15 | VERA | Turner William D. | Chief Regulatory Off | S - Sale+OE | $50.08 | -10.0K | 22.5K | -31% | -$500.8K |
| 2025-12-15 | 2025-12-11 | VERA | ENRIGHT PATRICK G | Dir | P - Purchase | $42.50 | +5,882 | 5,882 | New | +$250.0K | |
| DT | 2025-12-10 | 2025-12-08 | VERA | Turner William D. | Chief Regulatory Off | S - Sale+OE | $45.31 | -10.0K | 22.5K | -31% | -$453.1K |
| DT | 2025-12-10 | 2025-12-08 | VERA | Turner William D. | Chief Regulatory Off | M - OptEx | $15.53 | +10.0K | 32.5K | +44% | +$155.3K |
| DT | 2025-12-04 | 2025-12-03 | VERA | Turner William D. | Chief Regulatory Off | S - Sale+OE | $40.00 | -10.0K | 22.5K | -31% | -$400.0K |
| DT | 2025-12-04 | 2025-12-03 | VERA | Turner William D. | Chief Regulatory Off | M - OptEx | $15.53 | +10.0K | 32.5K | +44% | +$155.3K |
| 2025-11-25 | 2025-11-21 | VERA | Carter Jason S | CLO | S - Sale | $27.82 | -3,864 | 49.1K | -7% | -$107.5K | |
| D | 2025-11-13 | 2025-11-13 | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | M - OptEx | $3.94 | +10.0K | 57.8K | +21% | +$39.4K |
| D | 2025-11-13 | 2025-11-11 | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | S - Sale+OE | $29.06 | -15.0K | 47.8K | -24% | -$435.9K |
| MI | 2025-06-25 | 2025-06-23+ | VERA | ENRIGHT PATRICK G | Dir | P - Purchase | $21.11 | +250.0K | 3.57M | +8% | +$5.28M |
| M | 2025-02-27 | 2025-02-21+ | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $27.78 | -19.7K | 204.7K | -9% | -$546.9K |
| D | 2025-02-20 | 2025-02-18 | VERA | Grant Sean | CFO | A - Grant | $0.00 | +26.9K | 93.2K | +41% | $0 |
| D | 2025-02-20 | 2025-02-18 | VERA | JOHNSON DAVID LEE | COO | A - Grant | $0.00 | +26.9K | 26.9K | New | $0 |
| D | 2025-02-20 | 2025-02-18 | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | A - Grant | $0.00 | +10.7K | 61.9K | +21% | $0 |
| D | 2025-02-20 | 2025-02-18 | VERA | Brenner Robert | Chief Medical Off | A - Grant | $0.00 | +26.9K | 27.5K | +4,686% | $0 |
| D | 2025-02-20 | 2025-02-18 | VERA | Fordyce Marshall | Pres AND CEO, Dir | A - Grant | $0.00 | +80.8K | 224.4K | +56% | $0 |
| D | 2025-02-20 | 2025-02-18 | VERA | Turner William D. | Chief Development Off | A - Grant | $0.00 | +22.5K | 22.5K | New | $0 |
| DM | 2025-01-10 | 2025-01-08 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +17.5K | 149.3K | +13% | +$50.8K |
| DM | 2025-01-10 | 2025-01-08 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $41.74 | -17.5K | 143.6K | -11% | -$730.5K |
| DM | 2024-12-20 | 2024-12-18+ | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +75.2K | 91.0K | +476% | +$218.0K |
| DM | 2024-12-20 | 2024-12-18 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $43.07 | -17.5K | 85.9K | -17% | -$753.7K |
| DM | 2024-12-13 | 2024-12-11 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $46.94 | -17.5K | 85.9K | -17% | -$821.5K |
| DM | 2024-12-13 | 2024-12-11 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +17.5K | 87.7K | +25% | +$50.8K |
| DM | 2024-11-27 | 2024-11-25 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $47.98 | -19.4K | 85.9K | -18% | -$929.5K |
| DM | 2024-11-27 | 2024-11-25 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +19.4K | 93.6K | +26% | +$56.2K |
| D | 2024-11-20 | 2024-11-18 | VERA | Carter Jason S | CLO | A - Grant | $0.00 | +53.0K | 53.0K | New | $0 |
| DM | 2024-11-15 | 2024-11-13 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $49.50 | -30.6K | 85.9K | -26% | -$1.52M |
| DM | 2024-11-15 | 2024-11-13 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +30.6K | 89.2K | +52% | +$88.8K |
| M | 2024-10-30 | 2024-10-28 | VERA | SEIDENBERG BETH C | Dir | S - Sale | $48.03 | -15.0K | 131.6K | -10% | -$720.5K |
| DM | 2024-10-25 | 2024-10-23 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $40.40 | -19.4K | 308.0K | -6% | -$782.7K |
| DM | 2024-10-25 | 2024-10-23 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +19.4K | 310.3K | +7% | +$56.2K |
| DM | 2024-10-11 | 2024-10-09 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $38.24 | -15.6K | 308.0K | -5% | -$597.5K |
| DM | 2024-10-11 | 2024-10-09 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +15.6K | 320.2K | +5% | +$45.3K |
| DM | 2024-09-27 | 2024-09-25 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +23.1K | 308.9K | +8% | +$67.1K |
| DM | 2024-09-27 | 2024-09-25 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $46.05 | -23.1K | 308.0K | -7% | -$1.06M |
| M | 2024-09-20 | 2024-09-18+ | VERA | SEIDENBERG BETH C | Dir | S - Sale | $42.29 | -15.0K | 146.6K | -9% | -$634.3K |
| I | 2024-09-20 | 2024-09-18 | VERA | SEIDENBERG BETH C | Dir | S - Sale | $42.00 | -1,476 | 4,012 | -27% | -$62.0K |
| DM | 2024-09-13 | 2024-09-11 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $37.50 | -15.6K | 308.0K | -5% | -$586.0K |
| DM | 2024-09-13 | 2024-09-11 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +15.6K | 317.2K | +5% | +$45.3K |
| DM | 2024-08-30 | 2024-08-28 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $36.84 | -30.3K | 308.7K | -9% | -$1.12M |
| DM | 2024-08-30 | 2024-08-28 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +15.6K | 323.4K | +5% | +$45.3K |
| 2024-08-23 | 2024-08-21 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $39.76 | -14.5K | 322.7K | -4% | -$575.4K | |
| D | 2024-08-16 | 2024-08-14 | VERA | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +15.6K | 352.8K | +5% | +$45.3K |
| D | 2024-08-16 | 2024-08-14 | VERA | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $37.56 | -15.6K | 337.1K | -4% | -$586.9K |
| DM | 2024-05-17 | 2024-05-15+ | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | S - Sale+OE | $42.30 | -30.8K | 53.2K | -37% | -$1.30M |
| DM | 2024-05-17 | 2024-05-15+ | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | M - OptEx | $6.75 | +28.9K | 61.4K | +89% | +$194.9K |
| 2024-04-12 | 2024-04-10 | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | S - Sale | $40.00 | -5,714 | 53.2K | -10% | -$228.6K | |
| DMI | 2024-04-05 | 2024-04-03 | VERA | Grant Sean | CFO | S - Sale+OE | $39.42 | -18.6K | 0 | -100% | -$735.2K |
| D | 2024-04-05 | 2024-04-03 | VERA | Grant Sean | CFO | M - OptEx | $14.87 | +99.8K | 166.2K | +150% | +$1.48M |
| DM | 2024-04-05 | 2024-04-03 | VERA | Grant Sean | CFO | S - Sale+OE | $39.61 | -99.8K | 66.3K | -60% | -$3.95M |
| 2024-04-05 | 2023-03-14 | VERA | Grant Sean | CFO | G - Gift | $0.00 | -14.3K | 35.6K | -29% | $0 | |
| MI | 2024-04-05 | 2023-03-14+ | VERA | Grant Sean | CFO | G - Gift | $0.00 | +13.6K | 1,620 | New | $0 |
| MI | 2024-03-25 | 2024-03-21+ | VERA | Katabi Maha | Dir | S - Sale | $40.86 | -834.5K | 2.79M | -23% | -$34.10M |
| I | 2024-02-01 | 2024-01-30 | VERA | Katabi Maha | Dir | P - Purchase | $31.00 | +161.3K | 3.63M | +5% | +$5.00M |
| D | 2024-01-18 | 2024-01-16 | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | A - Grant | $0.00 | +21.9K | 57.1K | +62% | $0 |
| D | 2024-01-18 | 2024-01-16 | VERA | Grant Sean | CFO | A - Grant | $0.00 | +26.2K | 78.7K | +50% | $0 |
| D | 2024-01-18 | 2024-01-16 | VERA | Fordyce Marshall | Pres AND CEO, Dir | A - Grant | $0.00 | +78.8K | 335.6K | +31% | $0 |
| I | 2024-01-12 | 2024-01-10 | VERA | COMMODORE CAPITAL LP | 10% | S - Sale | $18.00 | -1.05M | 4.40M | -19% | -$18.90M |
| DM | 2024-01-03 | 2023-12-29 | VERA | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $2.88 | +13.5K | 256.9K | +6% | +$38.9K |
| 2023-08-23 | 2023-08-21 | VERA | Fordyce Marshall | Pres, CEO, Dir | S - Sale | $16.66 | -5,210 | 243.4K | -2% | -$86.8K | |
| 2023-08-23 | 2023-08-21 | VERA | Curley Joanne | Chief Development Off | S - Sale | $16.66 | -1,490 | 27.0K | -5% | -$24.8K | |
| 2023-08-23 | 2023-08-21 | VERA | Lin Celia | Chief Medical Off | S - Sale | $16.65 | -1,490 | 11.0K | -12% | -$24.8K | |
| D | 2023-07-06 | 2023-07-05 | VERA | Young Joseph R | SVP, Fin, Chief Acct Offcr | M - OptEx | $3.94 | +10.0K | 32.7K | +44% | +$39.4K |
| I | 2023-06-23 | 2023-06-23 | VERA | Grant Sean | CFO | P - Purchase | $16.60 | +5,000 | 5,992 | +504% | +$83.0K |
| I | 2023-06-22 | 2023-06-20 | VERA | COMMODORE CAPITAL LP | 10% | P - Purchase | $15.17 | +448.2K | 5.45M | +9% | +$6.80M |
| I | 2023-04-03 | 2023-03-30 | VERA | SEIDENBERG BETH C | Dir | P - Purchase | $7.24 | +2,300 | 1.95M | +0.1% | +$16.7K |
| I | 2023-03-30 | 2023-03-28 | VERA | SEIDENBERG BETH C | Dir | P - Purchase | $7.24 | +23.9K | 1.95M | +1% | +$173.1K |
Purchase Sale Sale after option exercise All abbreviations